Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANDEN N. E., ROOS B. E., WERDINIUS B. ON THE OCCURRENCE OF HOMOVANILLIC ACID AND 3-METHOXY-4-HYDROXYMANDELIC ACID IN HUMAN CEREBROSPINAL FLUID. Experientia. 1963 Jul 15;19:359–360. doi: 10.1007/BF02152317. [DOI] [PubMed] [Google Scholar]
- ASHCROFT G. W., SHARMAN D. F. 5-Hydroxyindoles in human cerebrospinal fluids. Nature. 1960 Jun 25;186:1050–1051. doi: 10.1038/1861050a0. [DOI] [PubMed] [Google Scholar]
- ASHCROFT G. W., SHARMAN D. F. Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Br J Pharmacol Chemother. 1962 Aug;19:153–160. doi: 10.1111/j.1476-5381.1962.tb01436.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BOGDANSKI D. F., WEISSBACH H., UDENFRIEND S. The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J Neurochem. 1957;1(3):272–278. doi: 10.1111/j.1471-4159.1957.tb12082.x. [DOI] [PubMed] [Google Scholar]
- Bernheimer H., Birkmayer W., Hornykiewicz O. Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien Klin Wochenschr. 1966 Jun 10;78(23):417–419. [PubMed] [Google Scholar]
- CARLSSON A., HILLARP N. A. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiol Scand. 1962 May;55:95–100. doi: 10.1111/j.1748-1716.1962.tb02422.x. [DOI] [PubMed] [Google Scholar]
- Guldberg H. C., Ashcroft G. W., Crawford T. B. Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci. 1966 Sep;5(17):1571–1575. doi: 10.1016/0024-3205(66)91026-5. [DOI] [PubMed] [Google Scholar]
- Guldberg H. C., Yates C. M. Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid. Br J Pharmacol Chemother. 1968 Jul;33(3):457–471. doi: 10.1111/j.1476-5381.1968.tb00494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Juorio A. V., Sharman D. F., Trajkov T. The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents. Br J Pharmacol Chemother. 1966 Feb;26(2):385–392. doi: 10.1111/j.1476-5381.1966.tb01918.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAVERTY R., SHARMAN D. F. MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN. Br J Pharmacol Chemother. 1965 Jun;24:759–772. doi: 10.1111/j.1476-5381.1965.tb01632.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSENGREN E. On the role of monoamine oxidase for the inactivation of dopamine in brain. Acta Physiol Scand. 1960 Aug 25;49:370–375. doi: 10.1111/j.1748-1716.1960.tb01959.x. [DOI] [PubMed] [Google Scholar]
- SHARMAN D. F. A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Br J Pharmacol Chemother. 1963 Feb;20:204–213. doi: 10.1111/j.1476-5381.1963.tb01310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEIL-MALHERBE H. The fluorimetric estimation of catechol compounds by the ethylenediamine condensation method. Pharmacol Rev. 1959 Jun;11(2 Pt 2):278–288. [PubMed] [Google Scholar]